Консервативное лечение миастении в условиях миастенического центра

Романова Татьяна Валентиновна · Неврология, нейропсихиатрия, психосоматика · 2013

The paper analyzes the results of treatment in 373 patients included in the Samara Region’s register of myasthenia gravis. The average disease duration was 9.7±7.6 years. Treatment encompassed symptom control with acetylcholinesterase inhibitors and immunosuppressive therapy. To achieve remission and good compensation, most cases needed the combined use of anticholinesterase inhibitors and immunosuppression with glucocorticoids and/or cytostatics. The efficiency of glucocorticoid and cytostatic therapies did not differ essentially. The adverse reactions of the treatment were evaluated. Therapy could achieve stabilization and improvement in 88.2% of cases.

Cited by 0 works.

Authors

References